semaglutide huberman Gwyneth Paltrow, Andrew & Retatrutide semaglutide huberman Andrew Hardaway, Ph.D.,

Semaglutide addresses the neurobiology directly: GLP-1 receptor agonism in the arcuate nucleus suppresses appetite signaling, and mesolimbic GLP-1 receptor activity reduces the reward salience of food that drives compulsive and excess eating

It works by improving energy use in the body and boosting acetylcholine

Many patients wonder whether they can accelerate this process or combine doses, but understanding the clinical rationale behind the dosing schedule helps explain why this approach is designed the way it is

Nutrition may vary based on methods of preparation, origin, serving size and freshness of ingredients, among other factors

Pennsylvania eliminated Medicaid coverage of GLP-1s for weight loss starting in January 2026 and other states may follow

Your medication arrives with the same safety certifications and quality documentation as Ozempic, minus the premium pricing